<DOC>
	<DOCNO>NCT02587975</DOCNO>
	<brief_summary>This study design measure effect evogliptin bone metabolism healthy volunteer .</brief_summary>
	<brief_title>Effect Evogliptin Bone Metabolism Human</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<criteria>Postmenopausal healthy woman ( least 5 year ) BMI 18~30 kg/m2 Presence history hypersensitivity allergic reaction drug Clinically relevant abnormal medical history present disease Presence history drug abuse Participation clinical trial within 2 month dose . Bood donation 2 month apheresis 1 month study . Use prescription medicine , herbal medicine within 2 week overthecounter medication vitamin substance within 1 week dose . Use drug affect bone metabolism sex hormone receptor related medicine , calcitonin parathyroid hormone related medicine , systemic corticosteroid , bisphosphate , etc . Smoking 10 cigarettes/days within 3 month first dose . Use alcohol 21 units/weeks Subject judge eligible study participation investigator .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>